MedTrace Logo

The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients

NCT00600405 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2008-01-25

No results posted yet for this study

Summary

The purpose of this study is to determine the efficacy of the α-adrenergic antagonist tamsulosin in the treatment of adult emergency department (ED) patients with ureteral colic secondary to lower ureteral calculus. We hypothesize that there will be no difference in outcomes for subjects treated with and without tamsulosin.

Conditions

  • Nephrolithiasis
  • Ureteral Calculi

Interventions

DRUG

tamsulosin

Tamsulosin 0.4 mg orally daily for ten days.

DRUG

Standard therapy with ibuprofen and oxycodone.

Oxycodone: 5mg, one to two tablets every four to six hours as needed for pain. Ibuprofen: 800 mg, one three times a day with food as needed for pain.

Sponsors & Collaborators

  • Maine Medical Center Mentored Research Committee

    collaborator UNKNOWN

  • MaineHealth

    lead OTHER

Principal Investigators

  • Andrew D Perron, MD · MaineHealth

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2007-11-30
Completion
2007-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00600405 on ClinicalTrials.gov